Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2008 1
2010 3
2011 1
2012 5
2013 2
2014 8
2015 6
2016 8
2017 9
2018 10
2019 5
2020 7
2021 5
2022 9
2023 4
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapeutic approaches for hepatocellular carcinoma.
Longo V, Gnoni A, Casadei Gardini A, Pisconti S, Licchetta A, Scartozzi M, Memeo R, Palmieri VO, Aprile G, Santini D, Nardulli P, Silvestris N, Brunetti O. Longo V, et al. Among authors: pisconti s. Oncotarget. 2017 May 16;8(20):33897-33910. doi: 10.18632/oncotarget.15406. Oncotarget. 2017. PMID: 28420805 Free PMC article. Review.
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.
Longo V, Tamma R, Brunetti O, Pisconti S, Argentiero A, Silvestris N, Ribatti D. Longo V, et al. Among authors: pisconti s. Clin Exp Med. 2018 Aug;18(3):319-323. doi: 10.1007/s10238-018-0493-6. Epub 2018 Feb 28. Clin Exp Med. 2018. PMID: 29492715 Review.
Melanoma Adjuvant Treatment: Current Insight and Clinical Features.
D'Aniello C, Perri F, Scarpati GDV, Pepa CD, Pisconti S, Montesarchio V, Wernert N, Zarone MR, Caraglia M, Facchini G, Berretta M, Cavaliere C. D'Aniello C, et al. Among authors: pisconti s. Curr Cancer Drug Targets. 2018;18(5):442-456. doi: 10.2174/1568009617666170208163714. Curr Cancer Drug Targets. 2018. PMID: 28183255 Review.
Thyroid cancer management: from a suspicious nodule to targeted therapy.
Perri F, Giordano A, Pisconti S, Ionna F, Chiofalo MG, Longo F, Leopardo D, Della Vittoria Scarpati G, Pezzullo L. Perri F, et al. Among authors: pisconti s. Anticancer Drugs. 2018 Jul;29(6):483-490. doi: 10.1097/CAD.0000000000000617. Anticancer Drugs. 2018. PMID: 29649016 Review.
Current and Emerging Treatments for Metastatic Renal Cell Carcinoma.
Cavaliere C, D'Aniello C, Pepa CD, Pisconti S, Berretta M, Facchini G. Cavaliere C, et al. Among authors: pisconti s. Curr Cancer Drug Targets. 2018;18(5):468-479. doi: 10.2174/1568009617666170209094030. Curr Cancer Drug Targets. 2018. PMID: 28183256 Review.
86 results